Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data.
Issue Date
2017-08-17Keywords
MEDICINES MANAGEMENTSTATISTICAL DATA
DATA ANALYSIS
PHARMACY
Metadata
Show full item recordCitation
Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data. 2017 Eur. J. Clin. Pharmacol.Journal
European journal of clinical pharmacologyDOI
10.1007/s00228-017-2310-7PubMed ID
28819675Additional Links
https://link.springer.com/article/10.1007/s00228-017-2310-7Abstract
Administrative health data, such as pharmacy claims data, present a valuable resource for conducting pharmacoepidemiological and health services research. Often, data are available for whole populations allowing population level analyses. Moreover, their routine collection ensures that the data reflect health care utilisation in the real-world setting compared to data collected in clinical trials.The Irish Health Service Executive-Primary Care Reimbursement Service (HSE-PCRS) community pharmacy claims database is described. The availability of demographic variables and drug-related information is discussed. The strengths and limitations associated using this database for conducting research are presented, in particular, internal and external validity. Examples of recently conducted research using the HSE-PCRS pharmacy claims database are used to illustrate the breadth of its use.
The HSE-PCRS national pharmacy claims database is a large, high-quality, valid and accurate data source for measuring drug exposure in specific populations in Ireland. The main limitation is the lack of generalisability for those aged <70 years and the lack of information on indication or outcome.
Item Type
ArticleLanguage
enISSN
1432-1041Sponsors
Administrative health data, such as pharmacy claims data, present a valuable resource for conducting pharmacoepidemiological and health services research. Often, data are available for whole populations allowing population level analyses. Moreover, their routine collection ensures that the data reflect health care utilisation in the real-world setting compared to data collected in clinical trials.ae974a485f413a2113503eed53cd6c53
10.1007/s00228-017-2310-7
Scopus Count
Collections
Related articles
- The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.
- Authors: Conte C, Vaysse C, Bosco P, Noize P, Fourrier-Reglat A, Despas F, Lapeyre-Mestre M
- Issue date: 2019 Apr
- Anticholinergic and sedative drug burden in community-dwelling older people: a national database study.
- Authors: Byrne CJ, Walsh C, Cahir C, Ryan C, Williams DJ, Bennett K
- Issue date: 2018 Jul 6
- How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database.
- Authors: Latry P, Molimard M, Bégaud B, Martin-Latry K
- Issue date: 2010 Jul
- Pharmacoepidemiology--an Irish perspective.
- Authors: Williams D, Feely J
- Issue date: 2001 Dec
- Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
- Authors: Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ
- Issue date: 2009 Jan-Feb